You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 5, November 1955 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Meclizine Hydrochloride (Bonamine) upon Vestibular Function

Observations with Notes on Its Value in Comparison with Cyclizine Hydrochloride (Marezine) and Dimenhydrinate (Dramamine)

LEONARD B. GUTNER, M.D.; WILBUR J. GOULD, M.D.; J. SWIFT HANLEY, M.D.

AMA Arch Otolaryngol. 1955;62(5):497-503.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Despite the many positive claims that have been made as to the efficacy of the various antivertiginous drugs now available, the search for a more effective compound with fewer side-reactions continues. Ideally, such medication, in addition to exhibiting a high degree of labyrinthine depression, should be relatively free of untoward sideeffects and possess an adequate duration of activity, thus eliminating the necessity for frequent administration. The preparation should, of course, be orally active and not interfere with the daily functions of the patient. Needless to say, such a compound has yet to be formulated.

One of the newer drugs suggested for use in disturbances of labyrinthine function and associated disorders is meclizine hydrochloride (Parachloramine, Postafene). Chemically, it is the dihydrochloride of 1 -p -chlorobenzhydryl-4-m-methylbenzylpiperazine, having the accompanying structural formula.

This compound has been found to possess antihistaminic and anticholinergic properties, either activity theoretically having some potential therapeutic value . . . [Full Text PDF of this Article]


Author Affiliations

New York

From the Departments of Therapeutics, New York University-Bellevue Medical Center and the Otorhinolaryngological Division of the New York Eye and Ear Infirmary, service of Dr. J. Swift Hanley.


Footnotes

Submitted for publication July 5, 1955.

References 2 to 5.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1955 American Medical Association. All Rights Reserved.